After this program was recorded, an exploratory analysis of the FIDELITY-DKD study released at the American Society of Nephrology’s Kidney Week 2021 confirmed the ability of finerenone to reduce renal outcomes in patients with CKD and type 2 diabetes, regardless of baseline therapy (e.g., SGLT2 inhibitors).

Screening and Management of Chronic and Diabetic Kidney Disease: How Does Your Approach Compare with the Experts’?


Robert Toto, MD
Professor of Medicine
University of Texas, Southwestern Medical Center
Dallas, TX

George Bakris, MD
Professor of Medicine
Director, American Heart Association, Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, IL

This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programing.


The case-based online activity will cover the treatment and management of patients with chronic and diabetic kidney disease (DKD).


This educational activity is designed for primary care clinicians, nurse practitioners, physician assistants, and other healthcare professionals with an interest in the management of patients with DKD.


Upon the completion of this program, attendees should be able to:

  • Assess the increased renal and CVD risks for patients with DKD that arise from pathophysiological mechanisms underlying CKD
  • Specify the drivers of CKD progression in patients with DKD including inflammation, fibrosis and activation of MRs
  • Facilitate earlier diagnosis of DKD through the use of evidence-based guideline screening assessments for CKD in the primary care setting
  • Evaluate data from recent clinical trials investigating renoprotective agents for the treatment of DKD
  • Recommend hyperkalemia risk mitigation strategies for patients with DKD receiving MRA therapy


Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.


Med Learning Group designates this online ativity for a maximum of 1.25 AMA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.


Purpose: This program would be beneficial for nurses involved in the care of patients with chronic and diabetic kidney disease.

CNE Credits: 1.25 ANCC Contact Hour.


Ultimate Medical Academy/(CCM) is accredited as a provider of nursing continuing professional education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.25 contact hour of continuing nursing education of RNs and APNs.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


Faculty Member Disclosures
Robert Toto, MD Discloses that he worked as a Consultant for Boehringer-Ingelheim, Bayer, Reaata, Medscape, ACI, Vifor, AstraZeneca. He also received contracted research fees from NIH
George Bakris, MD Discloses that he has received Consulting fees from Merck, Novo-Nordisk, Bayer, Vascular Dynamics, and Ionis

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose

Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Chris Drury, Medical Director of Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
Jessica Feygin, Program Coordinator of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.


Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.


There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the online post-test and evaluation.

You will receive your certificate as a downloadable file.


Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected].

RELEASE DATE: November 30, 2021

EXPIRATION DATE: November 30, 2022

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at


Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.